Form D · Other Health Care
CLEARFLOW, Inc
Irvine, CA · CIK 0001441046
Offering snapshot reported Aug 5, 2025 · SEC filing
- Reported sold
- $2.07M Offering amount: $4M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 24, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 5, 2025 | Initial | $2,067,348 | No comparison | 2 | SEC filing |
| Jun 28, 2024 | Initial | $2,323,358 | No comparison | 2 | SEC filing |
| Aug 25, 2020 | Initial | $7,506,772 | No comparison | 5 | SEC filing |
| May 15, 2019 | Initial | $7,553,776 | No comparison | 8 | SEC filing |
| Aug 13, 2018 | Amendment | $12,525,089 | $5,350,089vs Feb 27, 2018 | 6 | SEC filing |
| Feb 27, 2018 | Initial | $7,175,000 | No comparison | 5 | SEC filing |
| Aug 10, 2015 | Initial | $5,500,000 | No comparison | 2 | SEC filing |
| Nov 18, 2014 | Initial | $2,827,500 | No comparison | 3 | SEC filing |
| Feb 4, 2014 | Amendment | $4,200,000 | $450,000vs Nov 7, 2013 | 5 | SEC filing |
| Nov 7, 2013 | Initial | $3,750,000 | No comparison | 3 | SEC filing |
| Jan 5, 2012 | Initial | $4,900,000 | No comparison | 4 | SEC filing |
| Oct 5, 2010 | Initial | $1,247,587 | No comparison | 15 | SEC filing |
| Jul 13, 2010 | Initial | $105,000 | No comparison | 5 | SEC filing |
| Nov 25, 2009 | Initial | $690,500 | No comparison | 7 | SEC filing |
| Jul 23, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-553762
Convertible Promissory Note and Preferred Stock Warrants and the underlying preferred stock issuable upon conversion and exercise thereof.
Source: Form D, filed Aug 5, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Hannah Beathard | Executive |
| Edward M. Boyle | Director |
| Edward M. Boyle, Jr. | Director |
| James Fee | Director |
| Andrew D. Firlik | Director |
| Sam Kiderman | Director |
| Timothy Lynch | Director |
| Christopher Martin | Director |
| Paul Molloy | Director, Executive |
| Molloy Paul | Director, Executive |
| Ned Scheetz | Director |
| Alexander Suh | Director |
| Alex Suh | Director |
| George Trutza | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
16 Technology Dr., Suite 150
Irvine, CA, 92618
Irvine, CA, 92618